1 Flexner, C. HIV drug development: the next 25 years. Nat Rev Drug Discov 6, 959-966, doi:10.1038/nrd2336 (2007).
2 Beyrer, C. & Pozniak, A. HIV Drug Resistance - An Emerging Threat to Epidemic Control. N Engl J Med 377, 1605-1607, doi:10.1056/NEJMp1710608 (2017).
3 Kozal, M. et al. Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection. N Engl J Med 382, 1232-1243, doi:10.1056/NEJMoa1902493 (2020).
4 Bock, C. & Lengauer, T. Managing drug resistance in cancer: lessons from HIV therapy. Nature reviews. Cancer 12, 494-501, doi:10.1038/nrc3297 (2012).
5 Hu, W. S. & Hughes, S. H. HIV-1 reverse transcription. Cold Spring Harb Perspect Med 2, doi:cshperspect.a006882 [pii] 10.1101/cshperspect.a006882 (2012).
6 Lawitz, E. et al. Sofosbuvir for previously untreated chronic hepatitis C infection. N Engl J Med 368, 1878-1887, doi:10.1056/NEJMoa1214853 (2013).
7 Beigel, J. H. et al. Remdesivir for the Treatment of Covid-19 - Final Report. N Engl J Med 383, 1813-1826, doi:10.1056/NEJMoa2007764 (2020).
8 Balzarini, J. et al. Alpha-carboxy nucleoside phosphonates as universal nucleoside triphosphate mimics. Proc Natl Acad Sci U S A 112, 3475-3480, doi:10.1073/pnas.1420233112 (2015).
9 Das, K. et al. Conformational States of HIV-1 Reverse Transcriptase for Nucleotide Incorporation vs Pyrophosphorolysis-Binding of Foscarnet. ACS chemical biology 11, 2158-2164, doi:10.1021/acschembio.6b00187 (2016).
10 Mullins, N. D. et al. Exploring the role of the alpha-carboxyphosphonate moiety in the HIV-RT activity of alpha-carboxy nucleoside phosphonates. Organic & biomolecular chemistry 14, 2454-2465, doi:10.1039/c5ob02507a (2016).
11 Jochmans, D. et al. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action. J Virol 80, 12283-12292, doi:JVI.00889-06 [pii] 10.1128/JVI.00889-06 (2006).
12 Ruiz, F. X., Hoang, A., Das, K. & Arnold, E. Structural Basis of HIV-1 Inhibition by Nucleotide-Competing Reverse Transcriptase Inhibitor INDOPY-1. J Med Chem 62, 9996-10002, doi:10.1021/acs.jmedchem.9b01289 (2019).
13 Schramm, V. L. Enzymatic Transition States and Drug Design. Chem Rev 118, 11194-11258, doi:10.1021/acs.chemrev.8b00369 (2018).
14 Liu, S., Abbondanzieri, E. A., Rausch, J. W., Le Grice, S. F. & Zhuang, X. Slide into action: dynamic shuttling of HIV reverse transcriptase on nucleic acid substrates. Science 322, 1092-1097, doi:322/5904/1092 [pii] 10.1126/science.1163108 (2008).
15 Jansson, L. I. & Stone, M. D. Single-Molecule Analysis of Reverse Transcriptase Enzymes. Cold Spring Harb Perspect Biol 11, doi:10.1101/cshperspect.a032458 (2019).
16 Jhoti, H., Cleasby, A., Verdonk, M. & Williams, G. Fragment-based screening using X-ray crystallography and NMR spectroscopy. Curr Opin Chem Biol 11, 485-493, doi:10.1016/j.cbpa.2007.07.010 (2007).
17 Cox, O. B. et al. A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain. Chem Sci 7, 2322-2330, doi:10.1039/c5sc03115j (2016).
18 Wood, D. J. et al. FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation. J Med Chem 62, 3741-3752, doi:10.1021/acs.jmedchem.9b00304 (2019).
19 Collins, P. M. et al. Achieving a Good Crystal System for Crystallographic X-Ray Fragment Screening. Methods Enzymol 610, 251-264, doi:10.1016/bs.mie.2018.09.027 (2018).
20 Martinez, S. E., Bauman, J. D., Das, K. & Arnold, E. Structure of HIV-1 reverse transcriptase/d4TTP complex: Novel DNA cross-linking site and pH-dependent conformational changes. Protein science : a publication of the Protein Society 28, 587-597, doi:10.1002/pro.3559 (2019).
21 Scott, W. A. Structures of reverse transcriptase pre- and post-excision complexes shed new light on HIV-1 AZT resistance. Viruses 3, 20-25, doi:10.3390/v3010020 viruses-03-00020 [pii] (2011).
22 Tu, X. et al. Structural basis of HIV-1 resistance to AZT by excision. Nat Struct Mol Biol 17, 1202-1209, doi:nsmb.1908 [pii] 10.1038/nsmb.1908 (2010).
23 Huang, H., Chopra, R., Verdine, G. L. & Harrison, S. C. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 282, 1669-1675 (1998).
24 Sarafianos, S. G. et al. Trapping HIV-1 reverse transcriptase before and after translocation on DNA. J Biol Chem 278, 16280-16288, doi:10.1074/jbc.M212911200 M212911200 [pii] (2003).
25 Miller, M. T., Tuske, S., Das, K., DeStefano, J. J. & Arnold, E. Structure of HIV-1 reverse transcriptase bound to a novel 38-mer hairpin template-primer DNA aptamer. Protein science : a publication of the Protein Society 25, 46-55, doi:10.1002/pro.2776 (2016).
26 Abbondanzieri, E. A. et al. Dynamic binding orientations direct activity of HIV reverse transcriptase. Nature 453, 184-189, doi:nature06941 [pii] 10.1038/nature06941 (2008).
27 Haraguchi, Y., Sakurai, H., Hussain, S., Anner, B. M. & Hoshino, H. Inhibition of HIV-1 infection by zinc group metal compounds. Antiviral Res 43, 123-133, doi:10.1016/s0166-3542(99)00040-6 (1999).
28 Steitz, T. A. DNA polymerases: structural diversity and common mechanisms. J Biol Chem 274, 17395-17398 (1999).
29 Subramaniam, S., Earl, L. A., Falconieri, V., Milne, J. L. & Egelman, E. H. Resolution advances in cryo-EM enable application to drug discovery. Curr Opin Struct Biol 41, 194-202, doi:10.1016/j.sbi.2016.07.009 (2016).
30 Boland, A., Chang, L. & Barford, D. The potential of cryo-electron microscopy for structure-based drug design. Essays Biochem 61, 543-560, doi:10.1042/EBC20170032 (2017).
31 DeStefano, J. J. & Cristofaro, J. V. Selection of primer-template sequences that bind human immunodeficiency virus reverse transcriptase with high affinity. Nucleic Acids Res 34, 130-139, doi:10.1093/nar/gkj426 (2006).
32 Olimpo, J. T. & DeStefano, J. J. Duplex structural differences and not 2'-hydroxyls explain the more stable binding of HIV-reverse transcriptase to RNA-DNA versus DNA-DNA. Nucleic Acids Res 38, 4426-4435, doi:10.1093/nar/gkq169 (2010).
33 Song, X. P., Bouillon, C., Lescrinier, E. & Herdewijn, P. Iminodipropionic acid as the leaving group for DNA polymerization by HIV-1 reverse transcriptase. Chembiochem 12, 1868-1880, doi:10.1002/cbic.201100160 (2011).
34 Bauman, J. D. et al. Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design. Nucleic Acids Res 36, 5083-5092, doi:gkn464 [pii] 10.1093/nar/gkn464 (2008).
35 Douangamath, A. et al. Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source. J Vis Exp, doi:10.3791/62414 (2021).
36 Collins, P. M. et al. Gentle, fast and effective crystal soaking by acoustic dispensing. Acta Crystallogr D Struct Biol 73, 246-255, doi:10.1107/S205979831700331X (2017).
37 Powell, H. R., Battye, T. G. G., Kontogiannis, L., Johnson, O. & Leslie, A. G. W. Integrating macromolecular X-ray diffraction data with the graphical user interface iMosflm. Nat Protoc 12, 1310-1325, doi:10.1038/nprot.2017.037 (2017).
38 Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-221, doi:S0907444909052925 [pii] 10.1107/S0907444909052925 (2010).
39 Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30, 2785-2791, doi:10.1002/jcc.21256 (2009).
40 Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31, 455-461, doi:10.1002/jcc.21334 (2010).
41 Alexander, N., Woetzel, N. & Meiler, J. bcl::Cluster : A method for clustering biological molecules coupled with visualization in the Pymol Molecular Graphics System. IEEE Int Conf Comput Adv Bio Med Sci 2011, 13-18, doi:10.1109/ICCABS.2011.5729867 (2011).
42 Wallace, A. C., Laskowski, R. A. & Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8, 127-134, doi:10.1093/protein/8.2.127 (1995).
43 Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat Methods 14, 331-332, doi:10.1038/nmeth.4193 (2017).
44 Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J Struct Biol 192, 216-221, doi:10.1016/j.jsb.2015.08.008 (2015).
45 Pettersen, E. F. et al. UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem 25, 1605-1612, doi:10.1002/jcc.20084 (2004).
46 Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60, 2126-2132, doi:S0907444904019158 [pii]
10.1107/S0907444904019158 (2004).
47 Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr D Struct Biol 75, 861-877, doi:10.1107/S2059798319011471 (2019).